Postprandial triglycerides and blood coagulation

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue 4, 2001, Pages

  Silveira, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alimentary lipemia; Blood coagulation; Factor VII; Plasminogen activator inhibitor 1 (PAI 1); Postprandial triglycerides

Indexed keywords

BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9; ENZYME PRECURSOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

BLOOD CLOTTING; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DISEASE ASSOCIATION; FIBRINOLYSIS; HEART INFARCTION; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPOLYSIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034976674     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15115     Document Type: Conference Paper

References (56)

1. Effects of native, triglyceride-enriched and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells
2. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity. Studies in randomly selected normo- and hypertriglyceridemic men
3. Factor IX is activated in vivo by the tissue factor mechanism
4. Non-fasting factor VII coagulant activity (FVII:c) increased by high fat diet
5. Factor XI and protection of the fibrin clot against lysis - A role for the intrinsic pathway of the coagulation in fibrinolysis
6. Thrombinactivatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)
7. Fibrinogen, factor VII clotting activity and coronary artery disease severity
8. Increased PAI activity and PAI-1 antigen ocurring with an oral fat load: Associations with PAI-1 genotype and plasma active TGF-β levels
9. Quantitation of factor VII in plasma of normal and warfarin-treated individuals by radioimmunoassay
10. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals
11. Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state
12. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
13. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
14. Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease
15. Factor VII activity state in coronary artery disease
16. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease
17. Factor VII coagulant activity and antigen levels in men are determined by interaction between factor VII genotype and plasma triglyceride concentration
18. Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial tryglyceridemia in patients with ischemic heart disease confirmed by angiography
19. Fibrinolytic factors and the risk of myocardial infarction on sudden death in patients with angina pectoris
20. Coagulation factor VII and the risk of coronary heart disease in healthy men
21. Postprandial elevation of activated factor VII in young adults
22. Plasma lipoproteins enhance tissue-factor-independent factor VII activation
23. Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII
24. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis
25. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park heart study
26. Haemostatic function and cardiovascular death: Early results of a prospective study
27. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park heart study
28. Coagulation factor VII, dietary fat and blood lipids: A review
29. Postprandial response of activated factor VII in elderly women depends on the R353Q polymorphism
30. Activation of factor VII during alimentary lipemia occurs in healthy adults and in patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency
31. Plasma Factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition
32. Association between fat intake and factor VII coagulant activity - A predictor of cardiovascular mortality
33. Postprandial lipemia and haemostatic factors
34. Postprandial lipid metabolism and thrombosis
35. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration
36. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: A study in familial lipoprotein-lipase deficiency
37. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins
38. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface
39. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype
40. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
41. Hypertriglyceridemia and regulation of fibrinolytic activity
42. Effect of w-3 fatty acids and Simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia
43. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation
44. The relationship of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
45. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII
46. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects
47. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity
48. Post-prandial activation of coagulant factor VII by long-chain dietary fatty acids
49. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries
50. Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion
51. Elevated levels of factor VII activity in the postprandial state: Effect of the factor VII Arg-Gln polymorphism
52. Activation of coagulation factor VII during alimentary lipemia
53. In vivo demonstration that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway
54. Elevation of factor VII activity and mass in coronary artery disease of varying severity
55. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor
56. Measurement of basal levels of factor VIIa in hemophilia A and B patients